ProfileGDS4132 / 227485_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 31% 34% 25% 27% 30% 33% 28% 23% 30% 30% 34% 36% 34% 28% 37% 38% 33% 26% 31% 39% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10176.864831
GSM201543Muscle PCOS pioglitazone 12176.517234
GSM201544Muscle PCOS pioglitazone 16161.817825
GSM201545Muscle PCOS pioglitazone 20172.552327
GSM201829Muscle PCOS pioglitazone 23177.242230
GSM201830Muscle PCOS pioglitazon 25186.373933
GSM201831Muscle PCOS pioglitazone 27164.913428
GSM201832Muscle PCOS pioglitazone 3156.157723
GSM201833Muscle PCOS pioglitazone 4169.056930
GSM201834Muscle PCOS pioglitazone 8170.688130
GSM201835Muscle PCOS after pioglitazone 10270.583734
GSM201836Muscle PCOS after pioglitazone 12279.273936
GSM201837Muscle PCOS after pioglitazone 16271.260534
GSM201838Muscle PCOS after pioglitazone 20260.152928
GSM201839Muscle PCOS after pioglitazone 23286.797337
GSM201840Muscle PCOS after pioglitazone 25293.375638
GSM201841Muscle PCOS after pioglitazone 27269.181633
GSM201842Muscle PCOS after pioglitazone 3249.404126
GSM201843Muscle PCOS after pioglitazone 4276.007931
GSM201844Muscle PCOS after pioglitazone 8296.219339